Michael Khoo1, Ian Pressney2, Rikin Hargunani2, Asif Saifuddin2. 1. Department of Radiology, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex, HA7 4LP, UK. michael.khoo@rnoh.nhs.uk. 2. Department of Radiology, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex, HA7 4LP, UK.
Abstract
OBJECTIVE: Suspected soft-tissue sarcomas are typically investigated using magnetic resonance imaging (MRI), with a view to planning image-guided core needle biopsy for confirmation of the histological diagnosis. Indeterminate superficial lesions may be small and therefore potentially difficult to biopsy safely, such lesions possibly being more amenable to primary excision biopsy. The aim of this study is to determine the suitability of this practice in the setting of a specialist sarcoma service. MATERIALS AND METHODS: All patients referred over a 12-month period to the sarcoma service with a small (<3-cm), indeterminate, superficial soft-tissue mass according to MRI criteria, or a small lesion of the hand or foot deemed unsafe for percutaneous biopsy, and who underwent primary excision biopsy were included. The histology results were categorized into neoplastic and non-neoplastic lesions, and assessed for resection completeness. RESULTS: Fifty-eight patients fulfilled the inclusion criteria from all patients referred to the sarcoma service in a 12-month period. Of these, 42 out of 58 (72.4%) had benign neoplasms, 4 out of 58 (6.9%) had malignant tumours, 2 out of 58 (3.4%) an intermediate grade lesion, while 10 out of 58 (17.2%) were non-neoplastic. All 4 malignant lesions were completely excised at the time of excision biopsy. CONCLUSIONS: Primary excision biopsy of small, indeterminate soft-tissue masses within the setting of a specialist sarcoma service is a suitable management option. Only a small proportion of small superficial soft-tissue lesions with indeterminate MRI features are malignant tumours.
OBJECTIVE: Suspected soft-tissue sarcomas are typically investigated using magnetic resonance imaging (MRI), with a view to planning image-guided core needle biopsy for confirmation of the histological diagnosis. Indeterminate superficial lesions may be small and therefore potentially difficult to biopsy safely, such lesions possibly being more amenable to primary excision biopsy. The aim of this study is to determine the suitability of this practice in the setting of a specialist sarcoma service. MATERIALS AND METHODS: All patients referred over a 12-month period to the sarcoma service with a small (<3-cm), indeterminate, superficial soft-tissue mass according to MRI criteria, or a small lesion of the hand or foot deemed unsafe for percutaneous biopsy, and who underwent primary excision biopsy were included. The histology results were categorized into neoplastic and non-neoplastic lesions, and assessed for resection completeness. RESULTS: Fifty-eight patients fulfilled the inclusion criteria from all patients referred to the sarcoma service in a 12-month period. Of these, 42 out of 58 (72.4%) had benign neoplasms, 4 out of 58 (6.9%) had malignant tumours, 2 out of 58 (3.4%) an intermediate grade lesion, while 10 out of 58 (17.2%) were non-neoplastic. All 4 malignant lesions were completely excised at the time of excision biopsy. CONCLUSIONS: Primary excision biopsy of small, indeterminate soft-tissue masses within the setting of a specialist sarcoma service is a suitable management option. Only a small proportion of small superficial soft-tissue lesions with indeterminate MRI features are malignant tumours.
Authors: Francesca D Beaman; Mark J Kransdorf; Tricia R Andrews; Mark D Murphey; Lynn K Arcara; James H Keeling Journal: Radiographics Date: 2007 Mar-Apr Impact factor: 5.333
Authors: Iris M Noebauer-Huhmann; Marc-André Weber; Radhesh K Lalam; Siegfried Trattnig; Klaus Bohndorf; Filip Vanhoenacker; Alberto Tagliafico; Carla van Rijswijk; Joan C Vilanova; P Diana Afonso; Martin Breitenseher; Ian Beggs; Philip Robinson; Milko C de Jonge; Christian Krestan; Johan L Bloem Journal: Semin Musculoskelet Radiol Date: 2015-12-22 Impact factor: 1.777
Authors: William M Mendenhall; Daniel J Indelicato; Mark T Scarborough; Robert A Zlotecki; C Parker Gibbs; Nancy P Mendenhall; Charles M Mendenhall; William F Enneking Journal: Am J Clin Oncol Date: 2009-08 Impact factor: 2.339